NCT01608243View on ClinicalTrials.gov

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts

PHASE1CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
AsthmaHouse Dust Mite Allergy
Interventions
BIOLOGICAL

SLIT tablets of house dust mite allergen extracts

10 dosing days

BIOLOGICAL

Matching placebo

10 dosing days

Trial Locations (1)

34295

CHU Arnaud de Villeneuve, Montpellier

Sponsors

Lead Sponsor

Stallergenes Greer
All Listed Sponsors
lead

Stallergenes Greer

INDUSTRY